Skip to content

Mobile MRI for Immediate Radiological Acute Cerebral Lesion Evaluation in Stroke

Mobile MRI for Immediate Radiological Acute Cerebral Lesion Evaluation in Stroke: Investigating the Use of a Small Mobile MRI Scanner to Aid Investigation of Stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06262217
Acronym
MIRACLES
Enrollment
200
Registered
2024-02-15
Start date
2023-11-11
Completion date
2024-08-01
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

This prospective observational study will evaluate the potential value of mobile MRI in patients with suspected or proven acute stroke and Transient Ischemic Attack (TIA), undertaking additional imaging in the emergency department, acute stroke unit, or outpatient settings, and comparing diagnostic accuracy, Diffusion-weighted imaging (DWI) lesion volume and detection of complications (brain swelling or haemorrhagic transformation). Information on ease of use, tolerability and image quality will also be gathered.

Detailed description

The study will investigate mobile MRI for immediate radiological acute cerebral lesion evaluation in Stroke. The objectives are: 1. Among patients with possible acute minor stroke or TIA, to compare the detection rate of acute DWI lesions on mobile MRI scan with routine imaging, describe number and distribution of lesions, and describe the intervals between mobile MRI and routine diagnostic scan, and time to final clinical diagnosis 2. Among patients with acute stroke of uncertain onset time, to compare the presence of DWI-Fluid attenuated inversion recovery (FLAIR) mismatch pattern on mobile MRI with CT perfusion (CTP) mismatch. 3. Among patients with confirmed acute ischaemic stroke, to compare the volume of DWI lesion on mobile MRI with the core volume on CTP 4. Among patients with established stroke post-thrombolysis or thrombectomy, to compare the incidence of brain swelling and haemorrhagic transformation on mobile MRI with routine imaging 5. In all groups, to evaluate the tolerability and ease of use of the mobile MRI scanner, and to rate image quality

Interventions

DEVICEMobile MRI scanner

Use of mobile MRI scanner in patients with suspected or confirmed acute stroke (including Transient Ischaemic attacks)

Sponsors

University of Glasgow
CollaboratorOTHER
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or non-pregnant female \> or = 18 years of age * Clinically suspected stroke or transient ischaemic attack, or confirmed clinical diagnosis of stroke or TIA * Consent of patient or legal representative

Exclusion criteria

* Contraindications to MRI brain scan as per standard MRI checklist for NHS Greater Glasgow & Clyde

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic sensitivity and specificity of mobile MRI scanner1 weekIn patients with suspected or confirmed acute stroke (including transient ischaemic attack), what is the sensitivity and specificity of scans obtained with a mobile low field MRI scanner compared to routine diagnostic scanning

Secondary

MeasureTime frameDescription
Level of confidence in final diagnosis3 monthsLevel of confidence in final diagnosis on scale of possible, probable or definite
Comparison of MRI abnormalities1 weekNumber, size and location of mobile MRI abnormalities compared to routine scanning with MRI or CT (including CT perfusion scans to examine brain blood flow)
Patient Outcomes3 monthsDisability at 3 months after stroke using modified rankin scale with higher scores corresponding to worse outcomes
Time from arrival at the Emergency Department to scan2 weeksTime from hospital arrival to scan in acute patients
Use of treatments3 monthsUse of treatments (acute or to deal with complications of stroke)
Final Clinical Diagnosis3 monthsFinal clinical diagnosis and level of confidence in diagnosis

Countries

United Kingdom

Contacts

Primary ContactKeith W Muir, MD
keith.muir@glasgow.ac.uk+44 (0)141 451 5892

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026